Feb. 17, 2021—Vanderbilt biochemist Yi Ren is part of a team that has identified a new behavior of a SARS-CoV-2 protein and discovered that interfering with its function can block virus replication in host cells. This opens up the potential for new therapeutic targets for COVID-19.
Oct. 15, 2020—It might be possible to use vesicles carrying the receptor for SARS-CoV-2, the virus that causes COVID-19, to bind the virus and prevent infection.
Oct. 4, 2020—A new, $8.7 million project—Design. R–AI-assisted CPS Design—involves pathbreaking work for the Defense Advanced Research Projects Agency as future cyber-physical systems will rely less on human control and more machine learning algorithms and artificial intelligence processors.
Aug. 20, 2020—All software is not created equal. At one end are apps on a smartphone and consumer-facing programs for which periodic updates to fix bugs and security issues are routine, like replacing an air conditioning filter or getting an annual flu shot. At the other end are large, complex software systems such as software used in...
Jul. 15, 2020—Based on positive results in preclinical studies reported today, potently neutralizing antibodies identified by researchers at Vanderbilt University Medical Center are showing promise as a potential therapy for preventing and treating COVID-19.
May. 14, 2020—Vanderbilt Vaccine Center team isolates monoclonal antibodies against the mosquito-borne Ross River virus, which causes rash, fever and debilitating muscle and joint pain lasting three to six months.
Jun. 14, 2019—Scientists are testing a new way to fight chikungunya virus that involves injecting genetic material into the bodies of infected and at-risk individuals to trigger rapid production of potent, virus-neutralizing antibodies.
Mar. 14, 2019—Stimulating the vagus nerve triggers certain epigenetic changes involving learning and memory.
Feb. 7, 2019—Scientists at Vanderbilt's Institute for Software Integrated Systems have developed an award-winning AI to to help triage limited radio frequency demands in real time.
Jan. 25, 2019—Scientists at Vanderbilt University Medical Center and colleagues in Boston, Seattle and St. Louis are racing to develop — in a mere 90 days — a protective antibody-based treatment that can stop the spread of the Zika virus.
Mar. 15, 2018—A new integrated imaging approach makes it possible to probe the molecules involved in invasive infections and can be broadly applied to any health or disease state.
Jan. 30, 2018—The DARPA challenge seeks to uncover efficient solutions to our increasingly connected world's equally growing appetite for bandwidth.